The client had a low-molecular-weight heparin already on the market and wanted to monitor competitive activities on a continuous basis. The potential for missing important data was a major concern to the client because competitors could be presenting in a number of different therapeutic areas in which the client had little or no in-house expertise available to cover and track. Solutions:
Following in-depth client conversations, Rogers MIS provided a Competitor Preview that enabled the client to monitor all relevant competitors, including currently marketed drugs and drugs in development
The client gained the ability to view competitive abstracts from cross-therapeutic activity occurring at medical meetings information which would not have surfaced based on past client strategies
The Competitor Preview identified several meetings, previously not known to the client, where the client's own key opinion leaders acted as speakers. This enabled the client to update relevant slide kits for these speakers in a targeted and timely manner
In addition, the client was able to identify several opportunities to communicate key data to their target physicians from the newly discovered medical meeting activities Client Payoff:
The client achieved an increase in market share based on the ability to be on top of relevant activities from medical meetings and published literature alike
The client gained the ability to monitor pipeline products and continue to modify its own clinical trials in a proactive manner based on identification of future market trends, threats, and challenges
Finally, the client was able to improve its communication strategies by disseminating key data presented at worldwide medical meetings in multiple therapeutic areas
Client Scenario and Objectives:
Solutions:
Client Payoff:
)